SPONSOR

Yale University

Total Trials

Recruiting

Phases

Phase 1, Phase 2, Phase 3, EARLY_Phase 1

Conditions studied: Breast Cancer Hyperinsulinism HER2-negative Breast Cancer Appendicitis Depression Parkinson's Disease (PD)Perioperative/Postoperative Complications Aerobic Capacity HER2/Neu+ Uterine Serous Carcinoma Prostate Cancer

Yale University is a clinical research sponsor with 35 registered studies on ClinicalTrials.gov, of which 35 are actively recruiting participants. Research covers conditions including Breast Cancer, Hyperinsulinism, HER2-negative Breast Cancer, Appendicitis.

The trial portfolio spans Phase 1, Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Yale University

How many clinical trials has Yale University sponsored?

ClinicalMetric currently tracks 35 clinical trials sponsored by Yale University, of which 35 are actively recruiting participants. These trials cover conditions including Breast Cancer, Hyperinsulinism, HER2-negative Breast Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Yale University research focus on?

Yale University clinical trials span Breast Cancer, Hyperinsulinism, HER2-negative Breast Cancer, Appendicitis, Depression, and additional conditions. The research pipeline includes Phase 1, Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a Yale University clinical trial?

To participate in a Yale University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Yale University trials with current recruitment status updated daily.

Yale University

Frequently Asked Questions — Yale University

Clinical Trials by Yale University

Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy

Operative Versus Non-Operative Management for Appendicitis With Abscess or Phlegmon

The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease

SHAPE Test for Preoperative Risk Stratification

A Phase II Evaluation of Afatinib in Patients With Persistent or Recurrent HER2-positive Uterine Serous Carcinoma

The SUGAR Study; SBRT and Relugolix) for Prostate Cancer

A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherapy for High-Grade Appendiceal and Colorectal Adenocarcinoma With Peritoneal Metastasis

Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors

Empagliflozin in Patients With Cirrhosis and Ascites

Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response

Sex Differences in E-Cigarette Perception

Reestablishing Sleep and Circadian Alignment in Medical Intensive Care Unit (MICU) Patients Via a Mechanistic RCT of an Sleep Chronobundle

Real-World Effectiveness of Perinatal RSV Immunoprophylaxis

PRESSURE CHECK: Find Your Path to Better Health

tDCS for Laryngeal Dystonia

Long Term Evaluation of Scapular-inserted Contraceptive Implants

Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma

Standard Versus High Dose ED-Initiated Buprenorphine Induction

PTEN Hamartoma Tumor Syndrome Pediatric Patient Registry

Evaluating the Efficacy of a Mobile Application in Postoperative Rehabilitation

PoRI Clinical Trial

Iadademstat + SBRT With Atezo in ES-SCLC

Imaging Traumatic Stress and Alcohol Use Disorder With [18F]Bavarostat

Integrating PrEP Decision Making Into Counseling in Sexual and Reproductive Health Clinics

Intestinal Immunity in Neurologic Disease

Toward a Computationally-Informed, Personalized Treatment for Hallucinations

Evaluation of [18F]GATT-44 for Positron Emission Tomography Imaging of the GABA Transporter-1

Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide

Evaluation of the Clinical and Psychological Impact of Vitamin D Replacement in Adolescent Females at Risk for Polycystic Ovarian Syndrome (PCOS)

Pregnenolone for the Treatment of Alcohol Use Disorder

Substance Misuse and Family Violence Treatment Fathers

SV2 PET Imaging With [11C]APP311

Speech Motor Learning and Retention (Aim 1)

Imaging Phosphodiesterase 4B (PDE4B) in People With Psychiatric Disorders With Positron Emission Tomography (PET) and the Radiotracer [18F]PF974

Emergency Department-Initiated Medications for Alcohol Use Disorder